Your browser doesn't support javascript.
loading
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
Luckenbaugh, Amy N; Wallis, Christopher J D; Huang, Li-Ching; Wittmann, Daniela; Klaassen, Zachary; Zhao, Zighuo; Koyama, Tatsuki; Laviana, Aaron A; Conwill, Ralph; Goodman, Michael; Hamilton, Ann S; Wu, Xiao-Cheng; Paddock, Lisa E; Stroup, Antoinette; Cooperberg, Matthew R; Hashibe, Mia; O'Neil, Brock B; Kaplan, Sherrie H; Greenfield, Sheldon; Hoffman, Karen E; Penson, David F; Barocas, Daniel A.
Affiliation
  • Luckenbaugh AN; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wallis CJD; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Huang LC; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wittmann D; Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan.
  • Klaassen Z; Division of Urology, Medical College of Georgia at Augusta University, Augusta, Georgia.
  • Zhao Z; Georgia Cancer Center, Augusta, Georgia.
  • Koyama T; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Laviana AA; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Conwill R; Department of Surgery and Perioperative Care, Dell Medical School, Austin, Texas.
  • Goodman M; Office of Patient and Community Education, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hamilton AS; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.
  • Wu XC; Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.
  • Paddock LE; Department of Epidemiology, Louisiana State University Health Sciences Center New Orleans School of Public Health, New Orleans, Louisiana.
  • Stroup A; Department of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey.
  • Cooperberg MR; Department of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey.
  • Hashibe M; Department of Urology, University of California, San Francisco, California.
  • O'Neil BB; Department of Family and Preventative Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
  • Kaplan SH; Department of Urology, University of Utah Health, Salt Lake City, Utah.
  • Greenfield S; Department of Medicine, University of California Irvine, Irvine, California.
  • Hoffman KE; Department of Medicine, University of California Irvine, Irvine, California.
  • Penson DF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Barocas DA; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
J Urol ; 207(5): 1029-1037, 2022 05.
Article de En | MEDLINE | ID: mdl-34978488
ABSTRACT

PURPOSE:

We aimed to compare patient-reported mental health outcomes for men undergoing treatment for localized prostate cancer longitudinally over 5 years. MATERIALS AND

METHODS:

We conducted a prospective population-based analysis using the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study. Patient-reported depressive symptoms (Centers for Epidemiologic Studies Depression [CES-D]) and domains of the Medical Outcomes Study 36-item Short Form survey evaluating emotional well-being and energy/fatigue were assessed through 5 years after treatment with surgery, radiotherapy (with or without androgen deprivation therapy) and active surveillance. Regression models were adjusted for outcome-specific baseline function, demographic and clinicopathological characteristics, and treatment approach.

RESULTS:

A total of 2,742 men (median [quartiles] age 64 [59-70]) met inclusion criteria. Baseline depressive symptoms, as measured by the CES-D, were low (median 4, quartiles 1-8) without differences between groups. We found no effect of treatment modality on depressive symptoms (p=0.78), though older age, poorer health, being unmarried and baseline CES-D score were associated with declines in mental health. There was no clinically meaningful association between treatment modality and scores for either emotional well-being (p=0.81) or energy/fatigue (p=0.054).

CONCLUSIONS:

This prospective, population-based cohort study of men with localized prostate cancer showed no clinically important differences in mental health outcomes including depressive symptoms, emotional well-being, and energy/fatigue according to the treatment received (surgery, radiotherapy, or surveillance). However, we identified a number of characteristics associated with worse mental health outcomes including older age, poorer health, being unmarried, and baseline CES-D score which may allow for early identification of patients most at risk of these outcomes following treatment.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Antagonistes des androgènes Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans / Male / Middle aged Langue: En Journal: J Urol Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Antagonistes des androgènes Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans / Male / Middle aged Langue: En Journal: J Urol Année: 2022 Type de document: Article
...